Eileen works closely with investors in securities cases and has over a decade of experience in the legal world. She received her law degree from American University in 2005.
Bed Bath & Beyond Stock Lawsuit Investigation
Bed Bath & Beyond reports decline in same store sales; Stock plummets over 20%
Our firm is investigating potential clams on behalf of Bed Bath & Beyond investors. On February 11, 2020, Bed Bath & Beyond, Inc.reported a 5.4% decline in same-store sales, due in part to issues with inventory management and store traffic. Wall Street analysts voiced concerns that the company’s turnaround may now take longer than originally anticipated. On this news, Bed Bath & Beyond’s stock price dropped over 20% in one day, significantly harming investors.
Bed Bath & Beyond Stock Losses?
You may have a claim. Get a free and confidential consultation.
Bed Bath & Beyond Same-Store Sales Fall; BBBY Unexpected Margin Pressure
On February 11, 2020, Bed Bath & Beyond reported its preliminary fourth quarter 2019 financial results, disclosing a 5.4% decline in same-store sales. According to MarketWatch, the company attributed the sales decline to issues with inventory management, as well as slower store traffic and increased promotions and markdowns. The gross margin for the period also fell around 300 basis points, due largely to new promotions and higher online sales.
According to the CEO of Bed Bath & Beyond, Mark Tritton,
We are experiencing short-term pain in our efforts to stabilize the business, including the pressures of store traffic trends coupled with our own executional challenges.
Some analysts reported on the financial results as well. According to Wells Fargo analysts led by Zachary Fadem and quoted by MarketWatch,
In our view, this represents a discouraging start to the Tritton era, and while it’s widely understood that a Bed Bath & Beyond turnaround would be no easy task, we believe it’s safe to say that near-term improvement appears increasingly unlikely at this point
This announcement came a little over a month after the company withdrew its forecast for fiscal year 2019, Reuters states. On this news, shares of Bed Bath & Beyond dropped dramatically. Investors are encouraged to contact our firm about recovering their losses.
Our Securities Lawyers Have a Winning Record Against Companies Like Bed Bath & Beyond
Our securities lawyers have recovered over a billion dollars on behalf of our clients against behemoths, such as Chase Bank, Mastercard, and Anthem Blue Cross Blue Shield. Read more about our results.
You “shouldn’t presume that powerful banks and other powerful interests can just get away with doing bad things. Good, qualified counsel that are committed to a cause can usually figure out how to prosecute such cases effectively and prevail.”
–Eric Gibbs, award-winning securities attorney
Praise from the Courts
Federal judge in our AT&T class action:
“I’ve always found them to be extraordinary counsel in terms of their preparation and their professionalism.”
Federal judge in our Chase lawsuit (resulting in $100 million settlement):
They “fought tooth and nail, down to the wire” to achieve “the best settlement that they could under the circumstances.”
Read more about what judges say about us.
Gibbs Law Group's Financial Fraud Experience
Gibbs Law Group’s financial fraud and securities lawyers have more than two decades of experience prosecuting fraud. Our attorneys have successfully litigated against some of the largest companies in the United States, and we have recovered more than a billion dollars on our clients’ behalf.
We have fought some of the most complex cases brought under federal and state laws nationwide, and our attorneys have been recognized with numerous awards and honors for their accomplishments, including Top 100 Super Lawyers in Northern California, Top Plaintiff Lawyers in California, The Best Lawyers in America, and rated AV Preeminent (among the highest class of attorneys for professional ethics and legal skills).
Our Featured Securities Team
David’s advocacy has generated major recoveries for consumers impacted by financial fraud. He was named to the Top 40 Under 40 by Daily Journal and a “Rising Star in Class Actions” by Law360.
Amanda is spearheading a securities lawsuit against NantHealth concerning fraudulent statements to investors about the success of its key product.